J. C. Dobrowolsk et al.
148
[A62] d’Aniello A (2007) d-Aspartic acid: an endogenous amino acid with an important neuroendocrine role. Brain Res Rev 53:215–234
[A63] d’Aniello S, Somorjai I, garcia-Fernàndez J, topo E, d’Aniello A (2011) d-Aspartic acid
is a novel endogenous neurotransmitter. FASEB J 25:1014–1027
[A64] d’Aniello S, Spinelli P, Ferrandino g, Peterson K, tsesarskaja m, Fisher gh, d’Aniello A
(2005) Cephalopod vision involves dicarboxylic amino acids: d-aspartate, L-aspartate and
L-glutamate. Biochem J 386:331–340
[A65] Schell mJ, molliver mE, Snyder Sh (1995) d-serine, an endogenous synaptic modulator: localization to astrocytes and glutamate-stimulated release. Proc Natl Acad Sci u S A
92:3948–3952
[A66] Stechmiller JK (2005) Arginine supplementation and wound healing. Nutr Clin Pract
20:52–61
[A67] Witte mB, Barbul A (2003) Arginine physiology and its implication for wound healing.
Wound Rep Regen 11:419–423
[A68] daly Jm, Reynolds J, thom A, Kinsley L, dietrick-gallagher m, Shou J, Ruggieri B (1988)
Immune and metabolic effects of arginine in the surgical patient. 208:512–523
[A69] Wu g, Bazer FW, davis tA, Kim SW, Li P, Rhoads Jm, Satterfield mC, Smith SB, Spencer
tE, Yin Y (2009) Arginine metabolism and nutrition in growth, health and disease. Amino
Acids 37:153–168
[A70] Broome Jd (1968) Studies on the mechanism of tumor inhibition by L-asparaginase. Effects
of the enzyme on asparagine levels in the blood, normal tissues, and 6C3hEd lymphomas
of mice: differences in asparagine formation and utilization in asparaginase-sensitive and
-resistant lymphoma cells. J Exp med 127:1055–1072
[A71] Boos J, Werber g, Ahlke E, Schulze-Westhoff P, Nowak-göttl u, Würthwein g, verspohl
EJ, Ritter J, Jürgens h (1996) monitoring of asparaginase activity and asparagine levels in
children on different asparaginase preparations. Eur J Cancer 32A:1544–1550
[A72] Chakrabarti R, Schuster Sm (1997) L-asparaginase. Perspectives on the mechanisms of
action and resistance. Int J Pediatr hematol/oncol 4:597–611
[A73] Avramis vI, Panosyan Eh (2005) Pharmacokinetic/pharmacodynamic relationships of
asparaginase formulations: the past, the present and recommendations for the future. Clin
Pharmacokinet 44:367–393
[A74] Lea PJ, Sodek L, Parry mAJ, Shewry PR, halford Ng (2007) Asparagine in plants. Ann
Appl Biol 150:1–26
[A75] Stone tW, Burton NR (1988) NmdA receptors and ligands in the vertebrate CNS. Prog
Neurobiol 30:333–368
[A76] Barron Jt, gu L, Parrillo JE (1988) malate-aspartate shuttle, cytoplasmic NAdh redox
potential, and energetics in vascular smooth muscle. J mol Cell Cardiol 30:1571–1579
[A77] griffith oW (1999) Biologic and pharmacologic regulation of mammalian glutathione synthesis. Free Radic Biol med 27:922–935
[A78] Lo m, Wang YZ, gout PW (2008) the x(c)-cystine/glutamate antiporter: a potential target
for therapy of cancer and other diseases. J Cell Physiol 215(3):593–602
[A79] oven m, grill E, golan-goldhirsh A, Kutchan tm, Zenk mh (2002) Increase of free cysteine and citric acid in plant cells exposed to cobalt ions. Phytochemistry 60:467–474
[A80] Lacey Jm, Wilmore dW (1990) Is glutamine a conditionally essential amino acid? Nutr
Rev 48:297–309
[A81] Curi R, Lagranha CJ, doi SQ, Sellitti dF, Procopio J, Pithon-Curi tC, Corless m, Newsholme P (2005) molecular mechanisms of glutamine action. J Cell Physiol 204:392–401
[A82] Carmans S, hendriks JJ, thewissen K, van den Eynden J, Stinissen P, Rigo Jm, hellings N
(2010) the inhibitory neurotransmitter glycine modulates macrophage activity by activation of neutral amino acid transporters. J Neurosci Res 88:2420–2430
[A83] Yamadera W, Inagawa K, Chiba S, Bannai m, takahashi m, Nakayama K (2007) glycine
ingestion improves subjective sleep quality in human volunteers, correlating with polysomnographic changes. Sleep Biol Rhyt 5:126–131
148
[A62] d’Aniello A (2007) d-Aspartic acid: an endogenous amino acid with an important neuroendocrine role. Brain Res Rev 53:215–234
[A63] d’Aniello S, Somorjai I, garcia-Fernàndez J, topo E, d’Aniello A (2011) d-Aspartic acid
is a novel endogenous neurotransmitter. FASEB J 25:1014–1027
[A64] d’Aniello S, Spinelli P, Ferrandino g, Peterson K, tsesarskaja m, Fisher gh, d’Aniello A
(2005) Cephalopod vision involves dicarboxylic amino acids: d-aspartate, L-aspartate and
L-glutamate. Biochem J 386:331–340
[A65] Schell mJ, molliver mE, Snyder Sh (1995) d-serine, an endogenous synaptic modulator: localization to astrocytes and glutamate-stimulated release. Proc Natl Acad Sci u S A
92:3948–3952
[A66] Stechmiller JK (2005) Arginine supplementation and wound healing. Nutr Clin Pract
20:52–61
[A67] Witte mB, Barbul A (2003) Arginine physiology and its implication for wound healing.
Wound Rep Regen 11:419–423
[A68] daly Jm, Reynolds J, thom A, Kinsley L, dietrick-gallagher m, Shou J, Ruggieri B (1988)
Immune and metabolic effects of arginine in the surgical patient. 208:512–523
[A69] Wu g, Bazer FW, davis tA, Kim SW, Li P, Rhoads Jm, Satterfield mC, Smith SB, Spencer
tE, Yin Y (2009) Arginine metabolism and nutrition in growth, health and disease. Amino
Acids 37:153–168
[A70] Broome Jd (1968) Studies on the mechanism of tumor inhibition by L-asparaginase. Effects
of the enzyme on asparagine levels in the blood, normal tissues, and 6C3hEd lymphomas
of mice: differences in asparagine formation and utilization in asparaginase-sensitive and
-resistant lymphoma cells. J Exp med 127:1055–1072
[A71] Boos J, Werber g, Ahlke E, Schulze-Westhoff P, Nowak-göttl u, Würthwein g, verspohl
EJ, Ritter J, Jürgens h (1996) monitoring of asparaginase activity and asparagine levels in
children on different asparaginase preparations. Eur J Cancer 32A:1544–1550
[A72] Chakrabarti R, Schuster Sm (1997) L-asparaginase. Perspectives on the mechanisms of
action and resistance. Int J Pediatr hematol/oncol 4:597–611
[A73] Avramis vI, Panosyan Eh (2005) Pharmacokinetic/pharmacodynamic relationships of
asparaginase formulations: the past, the present and recommendations for the future. Clin
Pharmacokinet 44:367–393
[A74] Lea PJ, Sodek L, Parry mAJ, Shewry PR, halford Ng (2007) Asparagine in plants. Ann
Appl Biol 150:1–26
[A75] Stone tW, Burton NR (1988) NmdA receptors and ligands in the vertebrate CNS. Prog
Neurobiol 30:333–368
[A76] Barron Jt, gu L, Parrillo JE (1988) malate-aspartate shuttle, cytoplasmic NAdh redox
potential, and energetics in vascular smooth muscle. J mol Cell Cardiol 30:1571–1579
[A77] griffith oW (1999) Biologic and pharmacologic regulation of mammalian glutathione synthesis. Free Radic Biol med 27:922–935
[A78] Lo m, Wang YZ, gout PW (2008) the x(c)-cystine/glutamate antiporter: a potential target
for therapy of cancer and other diseases. J Cell Physiol 215(3):593–602
[A79] oven m, grill E, golan-goldhirsh A, Kutchan tm, Zenk mh (2002) Increase of free cysteine and citric acid in plant cells exposed to cobalt ions. Phytochemistry 60:467–474
[A80] Lacey Jm, Wilmore dW (1990) Is glutamine a conditionally essential amino acid? Nutr
Rev 48:297–309
[A81] Curi R, Lagranha CJ, doi SQ, Sellitti dF, Procopio J, Pithon-Curi tC, Corless m, Newsholme P (2005) molecular mechanisms of glutamine action. J Cell Physiol 204:392–401
[A82] Carmans S, hendriks JJ, thewissen K, van den Eynden J, Stinissen P, Rigo Jm, hellings N
(2010) the inhibitory neurotransmitter glycine modulates macrophage activity by activation of neutral amino acid transporters. J Neurosci Res 88:2420–2430
[A83] Yamadera W, Inagawa K, Chiba S, Bannai m, takahashi m, Nakayama K (2007) glycine
ingestion improves subjective sleep quality in human volunteers, correlating with polysomnographic changes. Sleep Biol Rhyt 5:126–131